Literature DB >> 21974762

Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individuals.

Eric Secemsky1, David Lange, David D Waters, Nora F Goldschlager, Priscilla Y Hsue.   

Abstract

Despite the increased risk of myocardial infarction, aortic dissection, and arrhythmias in patients with hypertension who use cocaine, the hemodynamic and arrhythmogenic effects of cocaine use have not been well characterized in this population. The authors hypothesized that patients with hypertension demonstrate extreme, transient changes in arterial pressures as well as new arrhythmic activity during cocaine use. Ambulatory blood pressures, heart rates, and electrocardiograms (AECGs) were recorded for 48 hours in 10 patients with a history of hypertension who smoke cocaine. Active cocaine use was identified through patient diaries and manual activation of the blood pressure cuff. Of the 10 patients studied (6 men, 7 African Americans, age 49±8 years), 8 were taking antihypertensive medications. The mean blood pressure prior to cocaine use was 126/77 mm Hg and average increase in systolic, diastolic, and mean arterial pressure after use was 74 mm Hg, 30 mm Hg, and 45 mm Hg, respectively (P<.0001 for all). There was no significant change in heart rate. AECGs demonstrated arrhythmic activity during cocaine use, including 6 patients with increased atrial and ventricular ectopy, 2 patients with episodes of nonsustained atrial tachycardia, and 1 patient with 3 episodes of nonsustained monomorphic ventricular tachycardia. Cocaine use resulted in extreme elevations in arterial pressures in patients with hypertension taking medication. Cocaine use was also associated with an increase in arrhythmic activity. These findings may underlie the heightened risk of myocardial infarction, aortic dissection, and potentially lethal arrhythmias in patients with hypertension who use cocaine.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21974762      PMCID: PMC8108995          DOI: 10.1111/j.1751-7176.2011.00520.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  37 in total

1.  Cardiovascular complications of cocaine use.

Authors:  R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

2.  Effects of intranasal cocaine on sympathetic nerve discharge in humans.

Authors:  T N Jacobsen; P A Grayburn; R W Snyder; J Hansen; B Chavoshan; C Landau; R A Lange; L D Hillis; R G Victor
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 3.  Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias.

Authors:  Michael E O'Leary; Jules C Hancox
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 4.  Effects of cocaine on the coronary arteries.

Authors:  B S Benzaquen; V Cohen; M J Eisenberg
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

5.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Authors:  Judith A Whitworth
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

6.  Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004.

Authors:  Jeffrey A Cutler; Paul D Sorlie; Michael Wolz; Thomas Thom; Larry E Fields; Edward J Roccella
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

7.  Left ventricular function immediately after intravenous cocaine: a quantitative two-dimensional echocardiographic study.

Authors:  M J Eisenberg; J Mendelson; G T Evans; J Jue; R T Jones; N B Schiller
Journal:  J Am Coll Cardiol       Date:  1993-11-15       Impact factor: 24.094

8.  Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable.

Authors:  Joseph P Broderick; Catherine M Viscoli; Thomas Brott; Walter N Kernan; Lawrence M Brass; Edward Feldmann; Lewis B Morgenstern; Janet Lee Wilterdink; Ralph I Horwitz
Journal:  Stroke       Date:  2003-05-22       Impact factor: 7.914

Review 9.  Noradrenaline release and the pathophysiology of primary human hypertension.

Authors:  M Esler; G Jennings; G Lambert
Journal:  Am J Hypertens       Date:  1989-03       Impact factor: 2.689

10.  The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension.

Authors:  Eduardo Oliver; Daniel Martí; Fermí Montó; Nicla Flacco; Lucrecia Moreno; Domingo Barettino; M Dolores Ivorra; Pilar D'Ocon
Journal:  J Pharmacol Exp Ther       Date:  2008-12-05       Impact factor: 4.030

View more
  2 in total

Review 1.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

2.  Electroacupuncture reduces cocaine-induced seizures and mortality in mice.

Authors:  Yi-Hung Chen; Boris Ivanic; Chieh-Min Chuang; Dah-Yuu Lu; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-17       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.